BRISTOL-MYERS SQUIBB COMPANY Restructuring and Related Cost, Number of Positions Eliminated
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Restructuring and Related Cost, Number of Positions Eliminated of 10000.00% for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2019-10-31
- BRISTOL-MYERS SQUIBB COMPANY restructuring and related cost, number of positions eliminated for the quarter ending 2019-03-31 was 5000.00%, a 50.00% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY restructuring and related cost, number of positions eliminated for the quarter ending 2018-03-31 was 10000.00%, a 88.89% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY restructuring and related cost, number of positions eliminated for the quarter ending 2017-03-31 was 90000.00%, a 800.00% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY restructuring and related cost, number of positions eliminated for the quarter ending 2016-03-31 was 10000.00%, a 59.18% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY restructuring and related cost, number of positions eliminated for fiscal 2018 was 90000.00%, a 52.63% decline from fiscal 2017.
- BRISTOL-MYERS SQUIBB COMPANY restructuring and related cost, number of positions eliminated for fiscal 2017 was 190000.00%, a 72.73% increase from fiscal 2016.
- BRISTOL-MYERS SQUIBB COMPANY restructuring and related cost, number of positions eliminated for fiscal 2016 was 110000.00%, a 8.33% decline from fiscal 2015.
- BRISTOL-MYERS SQUIBB COMPANY restructuring and related cost, number of positions eliminated for fiscal 2015 was 120000.00%, a 14.29% decline from fiscal 2014.
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 3 month | Restructuring and Related Cost, Number of Positions Eliminated 6 month | Restructuring and Related Cost, Number of Positions Eliminated 9 month | Restructuring and Related Cost, Number of Positions Eliminated 12 month | Restructuring and Related Cost, Number of Positions Eliminated 12 month as first filed |
|---|---|---|---|---|---|
| 2019-09-30 | 10000.00% 10-Q · filed 2019-10-31 | ||||
| 2019-06-30 | 10000.00% 10-Q · filed 2019-07-25 | ||||
| 2019-03-31 | 5000.00% 10-Q · filed 2019-04-25 | ||||
| 2018-12-31 | 90000.00% 10-K · filed 2019-02-25 | ||||
| 2018-09-30 | 60000.00% 10-Q · filed 2019-10-31 | ||||
| 2018-06-30 | 30000.00% 10-Q · filed 2019-07-25 | ||||
| 2018-03-31 | 10000.00% 10-Q · filed 2019-04-25 | ||||
| 2017-12-31 | 190000.00% 10-K · filed 2019-02-25 | ||||
| 2017-09-30 | 120000.00% 10-Q · filed 2018-10-25 | ||||
| 2017-06-30 | 100000.00% 10-Q · filed 2018-07-26 | ||||
| 2017-03-31 | 90000.00% 10-Q · filed 2018-04-26 | ||||
| 2016-12-31 | 110000.00% 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | 50000.00% 10-Q · filed 2017-10-26 | ||||
| 2016-06-30 | 20000.00% 10-Q · filed 2017-07-27 | ||||
| 2016-03-31 | 10000.00% 10-Q · filed 2017-04-27 | ||||
| 2015-12-31 | 120000.00% 10-K · filed 2018-02-13 | 116900.00% 10-K · filed 2016-02-12 | |||
| 2015-09-30 | 6000.00% 10-Q · filed 2015-10-27 | 68500.00% 10-Q · filed 2015-10-27 | |||
| 2015-06-30 | 38000.00% 10-Q · filed 2015-07-23 | 62500.00% 10-Q · filed 2015-07-23 | |||
| 2015-03-31 | 24500.00% 10-Q · filed 2015-04-28 | ||||
| 2014-12-31 | 140000.00% 10-K · filed 2017-02-21 | 138700.00% 10-K · filed 2015-02-13 | |||
| 2014-09-30 | 36000.00% 10-Q · filed 2015-10-27 | 76000.00% 10-Q · filed 2015-10-27 | |||
| 2014-06-30 | 22000.00% 10-Q · filed 2015-07-23 | 40000.00% 10-Q · filed 2015-07-23 | |||
| 2014-03-31 | 18000.00% 10-Q · filed 2015-04-28 | ||||
| 2013-12-31 | 145000.00% 10-K · filed 2016-02-12 | ||||
| 2013-09-30 | 15000.00% 10-Q · filed 2014-10-24 | 128500.00% 10-Q · filed 2014-10-24 | |||
| 2013-06-30 | 89000.00% 10-Q · filed 2014-07-24 | 113500.00% 10-Q · filed 2014-07-24 | |||
| 2013-03-31 | 24500.00% 10-Q · filed 2014-04-29 | ||||
| 2012-12-31 | 120500.00% 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | 18500.00% 10-Q · filed 2013-10-23 | 48000.00% 10-Q · filed 2013-10-23 | |||
| 2012-06-30 | 17500.00% 10-Q · filed 2013-07-25 | 29500.00% 10-Q · filed 2013-07-25 | |||
| 2012-03-31 | 12000.00% 10-Q · filed 2013-04-25 | ||||
| 2011-12-31 | 82200.00% 10-K · filed 2014-02-14 | ||||
| 2011-09-30 | 5000.00% 10-Q · filed 2012-10-24 | 70000.00% 10-Q · filed 2012-10-24 | |||
| 2011-06-30 | 21500.00% 10-Q · filed 2012-07-25 | 65000.00% 10-Q · filed 2012-07-25 | |||
| 2011-03-31 | 43500.00% 10-Q · filed 2012-04-26 | ||||
| 2010-12-31 | 99500.00% 10-K · filed 2013-02-15 | ||||
| 2010-09-30 | 6000.00% 10-Q · filed 2011-10-27 | 54000.00% 10-Q · filed 2011-10-27 | |||
| 2010-06-30 | 26000.00% 10-Q · filed 2011-07-28 | 48000.00% 10-Q · filed 2011-07-28 | |||
| 2009-12-31 | 135000.00% 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |